- Home
- BNY vs TKNO Comparison
BNY vs TKNO Comparison
Compare BNY & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BNY | TKNO |
|---|---|---|
| Founded | 2001 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 246.7M | 236.6M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | BNY | TKNO |
|---|---|---|
| Price | $10.07 | $4.04 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 52.7K | ★ 122.3K |
| Earning Date | 01-01-0001 | 11-06-2025 |
| Dividend Yield | ★ 3.93% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $39,801,000.00 |
| Revenue This Year | N/A | $8.79 |
| Revenue Next Year | N/A | $10.52 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 9.50 |
| 52 Week Low | $8.60 | $3.85 |
| 52 Week High | $10.80 | $10.37 |
Technical Indicators
Market Signals| Indicator | BNY | TKNO |
|---|---|---|
| Relative Strength Index (RSI) | 39.85 | 32.65 |
| Support Level | $10.10 | $3.85 |
| Resistance Level | $10.23 | $4.86 |
| Average True Range (ATR) | 0.07 | 0.29 |
| MACD | -0.01 | -0.06 |
| Stochastic Oscillator | 8.33 | 13.76 |
Price Performance
Historical ComparisonAbout BNY BlackRock New York Municipal Income Trust
Blackrock NY Municipal Income Tr investment objective is to provide shareholders with as high a level of current income exempt from U.S. federal income taxes and New York State and New York City personal income taxes as is consistent with its investment policies and prudent investment management.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.